Stock ScreenerStock IdeasBiotech BreakthroughsBest Biotech Stocks To Buy NowTop biotech stocks that analysts expect to be profitable within the next 3 years
Stock ScreenerStock IdeasBiotech Breakthroughs
Industry: Biotechnology
Forecast Earnings Growth: Positive
| Ticker | Company | Forecast Score | Market Cap | Price | Price Target | Upside/Downside | Consensus | Analysts | Fore. Revenue Growth | Fore. Earnings Growth | Forecast ROE | Forecast ROA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TECH | BIO-TECHNE CORP | $12.74B | $81.19 | $290.50 | 257.80% | Strong Buy | 8 | 13.75% | 125.98% | 97.88% | 72.92% | |
| BMRN | BIOMARIN PHARMACEUTICAL INC | $21.79B | $117.27 | $113.83 | -2.93% | Strong Buy | 12 | 25.56% | 109.60% | N/A | N/A | |
| ABCM | ABCAM PLC | $3.76B | $16.43 | $20.00 | 21.73% | Hold | 2 | 20.18% | 77.19% | 16.77% | 11.46% | |
| HRMY | HARMONY BIOSCIENCES HOLDINGS INC | $2.88B | $48.57 | $63.63 | 31.00% | Strong Buy | 8 | 32.60% | 24.30% | N/A | N/A | |
| GMAB | GENMAB A | $25.59B | $38.87 | $38.35 | -1.35% | Hold | 6 | 31.54% | 26.20% | N/A | N/A | |
| HALO | HALOZYME THERAPEUTICS INC | $6.86B | $50.71 | $60.71 | 19.73% | Strong Buy | 7 | 27.66% | 53.09% | N/A | N/A | |
| CSBR | CHAMPIONS ONCOLOGY INC | $55.73M | $4.11 | $15.00 | 264.96% | Strong Buy | 2 | 9.07% | 1,900.00% | 66.52% | 16.78% | |
| NBIX | NEUROCRINE BIOSCIENCES INC | $10.41B | $108.25 | $120.81 | 11.61% | Buy | 16 | 18.99% | 129.37% | N/A | N/A | |
| EXEL | EXELIXIS INC | $5.64B | $17.47 | $26.86 | 53.73% | Buy | 7 | 15.08% | 28.14% | N/A | N/A | |
| INCY | INCYTE CORP | $19.07B | $85.70 | $75.83 | -11.51% | Hold | 7 | 15.65% | 25.66% | N/A | N/A | |
| RPRX | ROYALTY PHARMA PLC | $23.62B | $38.90 | $52.67 | 35.39% | Strong Buy | 6 | 10.61% | 58.96% | N/A | N/A | |
| XOMA | XOMA CORP | $238.75M | $20.85 | $62.50 | 199.76% | Strong Buy | 3 | 15.00% | 42.57% | N/A | N/A | |
| XRTX | XORTX THERAPEUTICS INC | $7.98M | $0.61 | $17.50 | 2,750.16% | Strong Buy | 1 | N/A | 101.95% | N/A | N/A | |
| NVO | NOVO NORDISK A S | $312.30B | $138.09 | N/A | N/A | Buy | 4 | 15.74% | 21.72% | N/A | N/A | |
| VNDA | VANDA PHARMACEUTICALS INC | $432.91M | $7.65 | $12.00 | 56.86% | Hold | 1 | 2.43% | 34.55% | N/A | N/A | |
| PBYI | PUMA BIOTECHNOLOGY INC | $193.51M | $4.24 | $8.00 | 88.68% | Buy | 1 | 3.93% | 44.35% | N/A | N/A | |
| UTHR | UNITED THERAPEUTICS CORP | $11.84B | $259.68 | $279.82 | 7.75% | Buy | 12 | 12.97% | 13.28% | N/A | N/A | |
| ICPT | INTERCEPT PHARMACEUTICALS INC | $762.08M | $18.40 | $23.63 | 28.40% | Buy | 8 | 31.78% | 5.70% | N/A | N/A | |
| CPRX | CATALYST PHARMACEUTICALS INC | $1.62B | $15.52 | $20.38 | 31.28% | Strong Buy | 4 | 12.14% | 14.45% | N/A | N/A | |
| CORT | CORCEPT THERAPEUTICS INC | $2.50B | $23.26 | $30.00 | 28.98% | Buy | 3 | 13.56% | 18.68% | N/A | N/A | |
| VRTX | VERTEX PHARMACEUTICALS INC | $82.51B | $321.45 | $322.14 | 0.22% | Buy | 14 | 6.64% | 3.58% | N/A | N/A |
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.